Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-26

Clinical Trial Update: SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing terbinafine 1% topical solution to butenafine 1% topical solution for treating tinea pedis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUTENAFINE HYDROCHLORIDE (1%) topical liquid solution (butenafine hydrochloride)
  • TERBINAFINE HYDROCHLORIDE (1%) topical liquid solution (terbinafine hydrochloride)

Snippet

Sponsor: United Laboratories | Conditions: Tinea Pedis | Phase 2 | Status: UNKNOWN